关键词: biologic agents clinical guidelines for psoriasis dermatology guidelines monoclonal antibodies psoriasis skin disease

Mesh : Adalimumab / therapeutic use Antibodies, Monoclonal / therapeutic use Antibodies, Monoclonal, Humanized Biological Products / therapeutic use Biosimilar Pharmaceuticals / therapeutic use Certolizumab Pegol / therapeutic use Dermatologic Agents / therapeutic use Drug Therapy, Combination Etanercept / therapeutic use Evidence-Based Medicine Humans Infliximab / therapeutic use Piperidines / therapeutic use Psoriasis / drug therapy Pyrimidines / therapeutic use Pyrroles / therapeutic use Ustekinumab / therapeutic use

来  源:   DOI:10.1016/j.jaad.2018.11.057   PDF(Sci-hub)

Abstract:
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
摘要:
暂无翻译
公众号